Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2018-05-02
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Active-Controlled, Multi-center, Phase 3 Trial to Compare the
Safety and Efficacy between YHD1119 and Pregabalin in Patients with Peripheral Neuropathic
Pain